These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25253471)

  • 1. EEG-β/γ spectral power elevation in rat: a translatable biomarker elicited by GABA(Aα2/3)-positive allosteric modulators at nonsedating anxiolytic doses.
    Christian EP; Snyder DH; Song W; Gurley DA; Smolka J; Maier DL; Ding M; Gharahdaghi F; Liu XF; Chopra M; Ribadeneira M; Chapdelaine MJ; Dudley A; Arriza JL; Maciag C; Quirk MC; Doherty JJ
    J Neurophysiol; 2015 Jan; 113(1):116-31. PubMed ID: 25253471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.
    Paterson NE; Hanania T
    Behav Brain Res; 2010 Mar; 208(1):258-64. PubMed ID: 20006648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats.
    van Lier H; Drinkenburg WH; van Eeten YJ; Coenen AM
    Neuropharmacology; 2004 Aug; 47(2):163-74. PubMed ID: 15223295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test.
    Mathiasen LS; Rodgers RJ; Mirza NR
    Behav Pharmacol; 2007 May; 18(3):191-203. PubMed ID: 17426483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
    Lippa A; Czobor P; Stark J; Beer B; Kostakis E; Gravielle M; Bandyopadhyay S; Russek SJ; Gibbs TT; Farb DH; Skolnick P
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7380-5. PubMed ID: 15870187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and neurochemical evaluation of the effects of etizolam on GABAA receptors under normal and stress conditions.
    Sanna E; Pau D; Tuveri F; Massa F; Maciocco E; Acquas C; Floris C; Fontana SN; Maira G; Biggio G
    Arzneimittelforschung; 1999 Feb; 49(2):88-95. PubMed ID: 10083975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
    Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
    Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.
    Mathiasen L; Mirza NR
    Psychopharmacology (Berl); 2005 Nov; 182(4):475-84. PubMed ID: 16133136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
    Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
    J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiating effect of glabridin on GABAA receptor-mediated responses in dorsal raphe neurons.
    Jin Z; Kim S; Cho S; Kim IH; Han D; Jin YH
    Planta Med; 2013 Oct; 79(15):1408-12. PubMed ID: 23975867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.
    Mandema JW; Kuck MT; Danhof M
    Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.
    Atack JR; Hallett DJ; Tye S; Wafford KA; Ryan C; Sanabria-Bohórquez SM; Eng WS; Gibson RE; Burns HD; Dawson GR; Carling RW; Street LJ; Pike A; De Lepeleire I; Van Laere K; Bormans G; de Hoon JN; Van Hecken A; McKernan RM; Murphy MG; Hargreaves RJ
    J Psychopharmacol; 2011 Mar; 25(3):329-44. PubMed ID: 20156926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors.
    Vanover KE; Rosenzweig-Lipson S; Hawkinson JE; Lan NC; Belluzzi JD; Stein L; Barrett JE; Wood PL; Carter RB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):337-45. PubMed ID: 10991999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.
    Atack JR; Wafford KA; Street LJ; Dawson GR; Tye S; Van Laere K; Bormans G; Sanabria-Bohórquez SM; De Lepeleire I; de Hoon JN; Van Hecken A; Burns HD; McKernan RM; Murphy MG; Hargreaves RJ
    J Psychopharmacol; 2011 Mar; 25(3):314-28. PubMed ID: 20147571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia.
    Gee KW; Tran MB; Hogenkamp DJ; Johnstone TB; Bagnera RE; Yoshimura RF; Huang JC; Belluzzi JD; Whittemore ER
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1040-53. PubMed ID: 19940102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.